Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Anti-CD20 [2B8R1]

Product Type: Therapeutics (In Vivo)
Format: Anti-CD20, 2B8, rhesusized VR, rhesus IgG1 Fc
Clone ID: [2B8R1]
RRID: AB_2716323
Common Names: Anti-CD20 [2B8R1] | Depleting anti-CD20 (rhesus recombinant) | PR-2287 | NHP18
Target: CD20
Reactivity: Rhesus Macaque (Macaca mulatta) Human (Homo sapiens) Human Rhesus Cynomolgus Monkey
Applications: in vivo; depletion
Description:

2B8R1: Rhesus recombinant, CDR-grafted IgG1-kappa anti-CD20 antibody. Derived from rituximab.

* There is a new version of this product: Anti-CD20 [2B8R1F8]-Afucosylated *

 

How to cite this reagent

For your Materials & Methods section:

The rhesus IgG1 recombinant Anti-CD20 [2B8R1] monoclonal antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-2287, RRID:AB_2716323).

For your Acknowledgements  section:

"The Anti-CD20 [2B8R1] antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (P40 OD028116)".

Modifications: None
Restrictions: No
Sponsor: ORIP

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.